DK0764446T3 - Adjuveret vaccine, som i det væsentlige er fri for ikke-værtsalbumin - Google Patents
Adjuveret vaccine, som i det væsentlige er fri for ikke-værtsalbuminInfo
- Publication number
- DK0764446T3 DK0764446T3 DK96114505T DK96114505T DK0764446T3 DK 0764446 T3 DK0764446 T3 DK 0764446T3 DK 96114505 T DK96114505 T DK 96114505T DK 96114505 T DK96114505 T DK 96114505T DK 0764446 T3 DK0764446 T3 DK 0764446T3
- Authority
- DK
- Denmark
- Prior art keywords
- essentially free
- adjuvanted vaccine
- host albumin
- albumin
- host
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/21—Retroviridae, e.g. equine infectious anemia virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/118—Chlamydiaceae, e.g. Chlamydia trachomatis or Chlamydia psittaci
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/125—Picornaviridae, e.g. calicivirus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/23—Parvoviridae, e.g. feline panleukopenia virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
- A61K39/265—Infectious rhinotracheitis virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55588—Adjuvants of undefined constitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14311—Parvovirus, e.g. minute virus of mice
- C12N2750/14334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/16011—Caliciviridae
- C12N2770/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US53182095A | 1995-09-21 | 1995-09-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0764446T3 true DK0764446T3 (da) | 2006-12-11 |
Family
ID=24119189
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK96114505T DK0764446T3 (da) | 1995-09-21 | 1996-09-11 | Adjuveret vaccine, som i det væsentlige er fri for ikke-værtsalbumin |
Country Status (12)
Country | Link |
---|---|
US (1) | US7482020B2 (da) |
EP (1) | EP0764446B1 (da) |
JP (1) | JPH09110719A (da) |
AT (1) | ATE335508T1 (da) |
AU (1) | AU716702B2 (da) |
CA (1) | CA2184132C (da) |
DE (1) | DE69636427T2 (da) |
DK (1) | DK0764446T3 (da) |
ES (1) | ES2270433T3 (da) |
MX (1) | MX9604185A (da) |
NZ (1) | NZ299405A (da) |
PT (1) | PT764446E (da) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6682746B2 (en) | 1995-09-21 | 2004-01-27 | Kristina J. Hennessy | Adjuvanted vaccine which is substantially free of non-host albumin |
CA2184132C (en) * | 1995-09-21 | 2011-03-15 | Kristina J. Hennessy | An adjuvanted vaccine which is substantially free of non-host albumin |
BR9803232A (pt) | 1997-08-26 | 2000-01-11 | Pfizer Prod Inc | Vaicna de neospora. |
NZ504035A (en) | 1997-10-20 | 2002-04-26 | Bayer Ag | Neospora vaccines comprising Neospora caninum antigens |
KR100378909B1 (ko) * | 1998-03-18 | 2003-12-18 | 주식회사 엘지생명과학 | 사람세포주를이용한풍진백신의생산수율증대방법 |
BR9909789A (pt) | 1998-04-22 | 2000-12-26 | Genvec Inc | Método de purificação eficiente de adenovìrus |
CA2340682A1 (en) * | 1998-08-14 | 2000-02-24 | Aventis Pharmaceuticals Products Inc. | Adenovirus formulations for gene therapy |
RU2600798C2 (ru) | 2009-04-01 | 2016-10-27 | Юниверсити Оф Майами | Композиции вакцин и способы их применения |
CA2762586C (en) * | 2009-05-19 | 2018-06-19 | University Of Miami | Compositions, kits and methods for in vitro antigen presentation, assessing vaccine efficacy, and assessing immunotoxicity of biologics and drugs |
AU2011262312B2 (en) * | 2010-06-01 | 2015-05-28 | Novartis Ag | Concentration and lyophilization of influenza vaccine antigens |
CA3078625C (en) | 2017-10-09 | 2023-01-17 | Terumo Bct Biotechnologies, Llc | Lyophilization container and method of using same |
CA3130668A1 (en) | 2019-03-14 | 2020-12-03 | Terumo Bct Biotechnologies, Llc | Multi-part lyophilization container and method of use |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5540568B2 (da) * | 1972-10-05 | 1980-10-18 | ||
US4072565A (en) * | 1974-11-04 | 1978-02-07 | The Dow Chemical Company | Production of viruses in tissue culture without use of serum |
US4164565A (en) * | 1975-03-14 | 1979-08-14 | New York Blood Center, Inc. | Vaccine for active immunization containing hepatitis B surface antigen and associated antigen |
DE2630380A1 (de) * | 1975-07-14 | 1977-02-03 | Microlog Ltd | Verfahren zur herstellung einer vakzine |
JPS57194787A (en) * | 1981-05-28 | 1982-11-30 | Ajinomoto Co Inc | Culture medium for animal cell |
AU554859B2 (en) * | 1981-09-04 | 1986-09-04 | Regents Of The University Of California, The | Polymerized albumin vaccine |
US4458798A (en) * | 1981-12-03 | 1984-07-10 | Eaton Corporation | Rotary magnetic control for a viscous fluid coupling |
US4767622A (en) * | 1983-08-19 | 1988-08-30 | University Of Illinois | Method and materials for development of immunological responses protective against malarial infection |
WO1985000975A1 (en) * | 1983-08-19 | 1985-03-14 | University Of Illinois | Method and materials for development of immunological responses protective against malarial infection |
US5316926A (en) * | 1983-11-25 | 1994-05-31 | Miles Inc. | Method for the microbiological production of non-antigenic hyaluronic acid |
US4582798A (en) | 1984-11-23 | 1986-04-15 | Miles Laboratories, Inc. | Preparation and use of enzyme-detergent extracted Streptococcus equi vaccine |
US4957739A (en) * | 1987-08-13 | 1990-09-18 | Board Of Regents, The University Of Texas System | Pharmaceutical compositions of a 105 kD P. Haemolytica derived antigen useful for treatment of Shipping Fever |
JPS63210775A (ja) * | 1987-02-27 | 1988-09-01 | Doubutsuyou Seibutsugakuteki Seizai Kyokai | ニワトリ伝染性フアブリキウス襄病診断用抗原の分離精製方法 |
DE3852918T2 (de) * | 1987-09-28 | 1995-07-13 | Beecham Inc | TGEV-Virus vom Schwein als Impfstoff für Hunde. |
US5200179A (en) * | 1987-09-28 | 1993-04-06 | Beecham Group P.L.C. | Vaccine |
US5911999A (en) * | 1987-09-28 | 1999-06-15 | Pfizer, Inc. | Vaccine based on TGEV for protection of dogs against canine coronavirus |
US5376369A (en) * | 1987-11-03 | 1994-12-27 | Syntex (U.S.A.) Inc. | Vaccine adjuvant |
US5069901A (en) | 1988-02-03 | 1991-12-03 | Jones Elaine V | Preparation of a recombinant subunit vaccine against pseudorabies infection |
DE8910673U1 (de) * | 1989-09-07 | 1989-12-07 | Fa. Robert Schröder, 5600 Wuppertal | Betätigungsgriff für Schraubendreher |
WO1991008224A1 (en) * | 1989-11-24 | 1991-06-13 | The Council Of The Queensland Institute Of Medical Research | Im peptides |
US5583014A (en) | 1990-07-03 | 1996-12-10 | Bayer Corporation | Preparation and use of enzyme-detergent extracted Streptococcus zoopidemicus vaccine |
US5242686A (en) * | 1990-11-07 | 1993-09-07 | American Home Products Corporation | Feline vaccine compositions and method for preventing chlamydia infections or diseases using the same |
AU5873094A (en) * | 1992-12-23 | 1994-07-19 | Board Of Regents, The University Of Texas System | Multivalent ab1 antibodies as vaccines |
FR2708467B1 (fr) * | 1993-07-30 | 1995-10-20 | Pasteur Merieux Serums Vacc | Préparations d'immunoglobulines stabilisées et procédé pour leur préparation. |
AU701247B2 (en) * | 1993-11-03 | 1999-01-21 | Pfizer Inc. | Vaccine and method for treatment of chlamydial infections |
CA2184132C (en) * | 1995-09-21 | 2011-03-15 | Kristina J. Hennessy | An adjuvanted vaccine which is substantially free of non-host albumin |
US6682746B2 (en) * | 1995-09-21 | 2004-01-27 | Kristina J. Hennessy | Adjuvanted vaccine which is substantially free of non-host albumin |
-
1996
- 1996-08-26 CA CA2184132A patent/CA2184132C/en not_active Expired - Fee Related
- 1996-09-11 EP EP96114505A patent/EP0764446B1/en not_active Expired - Lifetime
- 1996-09-11 DK DK96114505T patent/DK0764446T3/da active
- 1996-09-11 AT AT96114505T patent/ATE335508T1/de not_active IP Right Cessation
- 1996-09-11 ES ES96114505T patent/ES2270433T3/es not_active Expired - Lifetime
- 1996-09-11 DE DE69636427T patent/DE69636427T2/de not_active Expired - Lifetime
- 1996-09-11 PT PT96114505T patent/PT764446E/pt unknown
- 1996-09-13 JP JP8263804A patent/JPH09110719A/ja active Pending
- 1996-09-18 NZ NZ299405A patent/NZ299405A/en not_active IP Right Cessation
- 1996-09-18 AU AU65691/96A patent/AU716702B2/en not_active Ceased
- 1996-09-19 MX MX9604185A patent/MX9604185A/es unknown
-
2003
- 2003-09-02 US US10/654,534 patent/US7482020B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2184132A1 (en) | 1997-03-22 |
CA2184132C (en) | 2011-03-15 |
MX9604185A (es) | 1997-03-29 |
DE69636427D1 (de) | 2006-09-21 |
EP0764446B1 (en) | 2006-08-09 |
NZ299405A (en) | 1997-08-22 |
PT764446E (pt) | 2006-12-29 |
US20050232948A1 (en) | 2005-10-20 |
ES2270433T3 (es) | 2007-04-01 |
US7482020B2 (en) | 2009-01-27 |
ATE335508T1 (de) | 2006-09-15 |
EP0764446A3 (en) | 1999-09-08 |
DE69636427T2 (de) | 2006-12-28 |
AU6569196A (en) | 1997-03-27 |
EP0764446A2 (en) | 1997-03-26 |
AU716702B2 (en) | 2000-03-02 |
JPH09110719A (ja) | 1997-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2038299T3 (es) | Grapa osea compresible. | |
DK0764446T3 (da) | Adjuveret vaccine, som i det væsentlige er fri for ikke-værtsalbumin | |
DK102894A (da) | Vaccine mod det porcine reproduktions- og respirationssyndrom | |
DE69229921D1 (de) | Zusammensetzung, Klebstoff sowie wässrige Emulsion | |
DE68906147D1 (de) | Gaspedal-steuereinrichtung. | |
BR8901053A (pt) | Regulador de pressao,e combinacao de valvula/regulador | |
DE3689150D1 (de) | Druckablass-, quell- und trocknungsvorrichtung. | |
BR9107294A (pt) | Derivados do GP160 e vacinas baseadas no GP160 ou um derivado do mesmo, contendo um adjuvante | |
ES2068919T3 (es) | Preparaciones nematicidas. | |
CA2025923A1 (en) | Stop for concrete formwork | |
FR2715994B1 (fr) | Dispositif aérostatique d'éclairage. | |
ES2063154T3 (es) | Vacuna asociada por afinidad. | |
DE58903225D1 (de) | Waessrige verbrennungskatalysatoren sowie brennstoffe. | |
DE68900931D1 (de) | Gewaechshaus, firstprofil und sprossenverbindung dafuer. | |
NO892665L (no) | Fluorerte primaerbelysningspreparater, deres anvendelse ogfremstilling. | |
ITRM940297A0 (it) | "dispositivo per la trasmissione di comandi manuali di accelerazione, frenatura e simili". | |
DE58906886D1 (de) | Druckluftbremseinrichtung. | |
DE69014252D1 (de) | Druckregler und Ventilbetätigungsvorrichtung. | |
FI941692A (fi) | Naula paisunta-alueella | |
EP0401262A4 (en) | 24r-scymnol, and preparation and use thereof | |
DE68912207D1 (de) | Gas-Laserapparat. | |
DK0729509T3 (da) | Vaccine imod fåresyge indeholdende en Jeryl-Lynn virus-stamme | |
NO900094D0 (no) | Gasstrykk-styreanordning. | |
ATE72327T1 (de) | Sicherungsvorrichtung fuer eine messeinrichtung. | |
AR005689A1 (es) | Dispositivo para fijar un riel |